FAS/FAS ligand ratio: a marker of oxaliplatin-based intrinsic and acquired resistance in advanced colorectal cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/16000573

Clin. Cancer Res. 2005 Jul 1 11 13 4770-4

Download in:

View as

Triples

General Info

PMID
16000573